| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.57 | 0.002 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.55 | 0.003 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |